Total cancer drug spending per patient suggested an increasing trend over the study period, growing at a CAGR of 5.1% and averaging €1,457 in 2015 across the included countries ( Fig 2C ).
← all excerpts
The cost of cancer - A comparative analysis of the direct medical costs of cancer and other major chronic diseases in Europe.
1
—
—